Cdk2/Cyclin Inhibitory Peptide II
Cdk2/Cyclin Inhibitory Peptide II (Tat-LDL), a CDK2 inhibitor, kills U2OS osteosarcoma cells in a dose-dependent manner.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 237392-85-7
- Fòrmula: C110H200N48O25
- Peso molecular:2595.07
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
Descripciòn
IC50 & Target
CDK[1].
In Vitro
Cdk2/Cyclin Inhibitory Peptide II (0-150 µM; 24 h) kills U2OS osteosarcoma cells in a dose-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:U2OS osteosarcoma cells
-
Concentration:0-150 µM
-
Incubation Time:24 h
-
Result:Exhibited good activity to kill U2OS osteosarcoma cells.
Chemical Information
-
No. CAS 237392-85-7
-
Peso molecular 2595.07
-
Fòrmula C110H200N48O25
-
SMILES
[YGRKKRRQRRRGPVKRRLDL]
-
Sequence Shortening
YGRKKRRQRRRGPVKRRLDL
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Cdk2/Cyclin Inhibitory Peptide II Related Classifications
HY-P3731 Related Classifications
Powered by Bioz